Skip to main content
Premium Trial:

Request an Annual Quote

IP Watch: Roche, Sequenom, Illumina, 3M, Others Win US Patents

Premium

Roche has been awarded US Patent No. 8,652,811, "Dry composition of reaction compounds with stabilized polymerase."

Thomas Metzler, Tobias Haslinger, Annette Peceny, and Harald Sobek are named as inventors.

Roche has also been awarded US Patent No. 8,652,775, "Alkyl amines improve detection of components of formaldehyde-fixed biological samples."

Stephen Will, Veeraiah Bodepudi, Ellen Fiss, and Rachel Shahinian are named as inventors.


Sequenom has been awarded US Patent No. 8,652,780, "Restriction endonuclease enhanced polymorphic sequence detection."

Mathias Ehrich and Dirk Van den Boom are named as inventors.


Genisphere has been awarded US Patent No. 8,653,251, "Methods and kits for nucleic acid amplification."

Robert Getts, James Kadushin, and Kelly Sensinger are named as inventors.


3M Innovative Properties has been awarded US Patent No. 8,652,812, "Dual oligonucleotide method of nucleic acid detection."

Jesse Miller is named as the inventor.


Illumina has been awarded US Patent No. 8,652,810, "Methods of nucleic acid amplification and sequencing."

Celine Adessi, Eric Kawashima, Pascal Mayer, Jean-Jacques Mermod, and Gerardo Turcatti are named as inventors.


Longhorn Vaccines & Diagnostics has been awarded US Patent No. 8,652,782, "Compositions and methods for detecting, identifying and quantitating mycobacterial-specific nucleic acids."

Gerald Fischer and Luke Daum are named as inventors.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.